My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.375 +0.025 (+1.85%)

Streaming Delayed Price Updated: 9:31 AM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

3 Small-Cap Stocks with Warning Signs

March 19, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

Topics Artificial Intelligence

Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders

March 17, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and it...

Via StockStory

Topics Artificial Intelligence

PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) Beats Q4 2025 Revenue and EPS Estimates ↗

February 12, 2026

Via Chartmill

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

3 of Wall Street’s Favorite Stocks We Think Twice About

March 13, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

Topics Economy

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)

March 03, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its ...

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks We Approach with Caution

March 01, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

February 27, 2026

A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key...

Via StockStory

Topics Economy Government Stocks

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

Via MarketMinute

Topics Earnings Economy World Trade

Why Is PacBio (PACB) Stock Soaring Today

February 24, 2026

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 6.3% in the afternoon session after the company announced a collaboration with DNAstack to launch the world's first...

Via StockStory

Topics Government Supply Chain World Trade

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Economy Government World Trade

PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?

February 19, 2026

PacBio’s 31.3% return over the past six months has outpaced the S&P 500 by 23.8%, and its stock price has climbed to $1.67 per share. This was partly thanks to its solid quarterly results, and the...

Via StockStory

Topics Bankruptcy Stocks

5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call

February 19, 2026

Pacific Biosciences’ fourth quarter results exceeded Wall Street’s expectations, supported by record consumables revenue and robust instrument placements, particularly for the Revio and Vega sequencing...

Via StockStory

Topics Earnings

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid

February 15, 2026

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears

February 13, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.8% year on year to $44.65 million. Its non-GAAP...

Via StockStory

PacBio (PACB) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

PacBio (PACB) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025

February 12, 2026

Via StockStory

PacBio Earnings: What To Look For From PACB

February 10, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

3 Cash-Burning Stocks We Approach with Caution

February 05, 2026

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

3 Stocks Under $10 with Warning Signs

January 27, 2026

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as...

Via StockStory

Topics Electric Vehicles

3 Unpopular Stocks That Concern Us

January 15, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...

Via StockStory

3 Reasons to Sell PACB and 1 Stock to Buy Instead

January 08, 2026

PacBio’s 38.9% return over the past six months has outpaced the S&P 500 by 28.4%, and its stock price has climbed to $2.06 per share. This performance may have investors wondering how to approach the...

Via StockStory

Topics Stocks

3 Unprofitable Stocks That Concern Us

January 04, 2026

Via StockStory

PacBio (PACB) Stock Is Up, What You Need To Know

January 02, 2026

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.9% in the morning session after news from a previous session revealed that Cathie Wood's investment firm, ARK Invest,...

Via StockStory

Topics Artificial Intelligence

Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24

January 02, 2026

Check out the companies making headlines this week:

Via StockStory

Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

January 01, 2026

Check out the companies making headlines yesterday:

Via StockStory

Why Is PacBio (PACB) Stock Soaring Today

December 31, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 6.1% in the afternoon session after Cathie Wood's investment firm, ARK Invest, purchased a substantial number of its...

Via StockStory

Topics Artificial Intelligence Supply Chain

2 Russell 2000 Stocks Worth Investigating and 1 Facing Challenges

December 24, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.